Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.89
Delayed Data
As of Jul 30
 -0.01 / -0.53%
Today’s Change
1.55
Today|||52-Week Range
5.00
-4.55%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.90
Today’s open1.89
Day’s range1.89 - 1.89
Volume100
Average volume (3 months)6,347
Market cap$22.6M
Dividend yield--
Data as of 9:29am ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+1.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.71

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.02-1.98%
BVXVBiondVax Pharmaceuti...-0.10-2.36%
EVOKEvoke Pharma Inc-0.10-1.96%
NUINNutrastar Internatio...0.000.00%
Data as of 3:59pm ET, 07/30/2015

Financials

Next reporting dateSeptember 7, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Chart unavailable